Evidence map›Paper›PMID 34521982›Full record

ArticleCommunications biology2021

Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk.

Daniel Ho, Denis M Nyaga, William Schierding, Richard Saffery, Jo K Perry, John A Taylor, Mark H Vickers, Andreas W Kempa-Liehr, Justin M O'Sullivan

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Daniel Ho *Liggins Institute, The University of Auckland, Auckland, New Zealand.
Denis M Nyaga *Liggins Institute, The University of Auckland, Auckland, New Zealand.
William SchierdingLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0001-5659-2701
Richard SafferyMurdoch Children Research Institute, The University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0002-9510-4181
Jo K PerryLiggins Institute, The University of Auckland, Auckland, New Zealand.
John A TaylorThe Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand.
Mark H VickersLiggins Institute, The University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0003-4876-9356
Andreas W Kempa-LiehrDepartment of Engineering Science, The University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0001-5558-0573
Justin M O'SullivanLiggins Institute, The University of Auckland, Auckland, New Zealand. justin.osullivan@auckland.ac.nz.ORCID http://orcid.org/0000-0003-2927-450X
University of Auckland · NZThe University of Melbourne · AU

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Wellcome Trust
6 · The paper itself

Abstract

Type 1 diabetes (T1D) etiology is complex. We developed a machine learning approach that ranked the tissue-specific transcription regulatory effects for T1D SNPs and estimated their relative contributions to conversion to T1D by integrating case and control genotypes (Wellcome Trust Case Control Consortium and UK Biobank) with tissue-specific expression quantitative trait loci (eQTL) data. Here we show an eQTL (rs6679677) associated with changes to AP4B1-AS1 transcript levels in lung tissue makes the largest gene regulatory contribution to the risk of T1D development. Luciferase reporter assays confirmed allele-specific enhancer activity for the rs6679677 tagged locus in lung epithelial cells (i.e. A549 cells; C > A reduces expression, p = 0.005). Our results identify tissue-specific eQTLs for SNPs associated with T1D. The strongest tissue-specific eQTL effects were in the lung and may help explain associations between respiratory infections and risk of islet autoantibody seroconversion in young children.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedChildChild, PreschoolDiabetes Mellitus, Type 1HumansLungMiddle AgedRisk AssessmentUnited KingdomYoung Adult

Identifiers

PMID34521982
PMCPMC8440780
OpenAlexW3200993608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.